Jinghe Huang

10PUBLICATIONS
40CO-AUTHORS
Molecular targetsInnate immunityMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 30, 2026
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or Mpro inhibitors.

Ruixue Xiu, Yuanzhou Wang, Wenbo Cai

|Jun 09, 2025
A potent and broad CD4 binding site neutralizing antibody with strong ADCC activity from a Chinese HIV-1 elite neutralizer.

Yingdan Wang, Ping Ji, Qianying Liu

|Feb 25, 2025
Synergistic impact of macrolide resistance and H3N2 infection on M. pneumoniae outbreak in children.

Jiali Chen, Yingdan Wang, Juan Cheng

|Jun 15, 2024
A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses.

Yingdan Wang, Aihua Hao, Ping Ji

|Mar 10, 2023
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.

Zezhong Liu, Jie Zhou, Xinling Wang

|Oct 07, 2022
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies.

Yingdan Wang, Xiang Zhang, Yunping Ma

Pageof 2

Frequent Collaborators

5 joint publications

Lu Lu

5 joint publications

Jincun Zhao

3 joint publications

Fan Wu

2 joint publications

Yanqun Wang